Resumen
Objetivo: Analizar el perfil clínico y epidemiológico de pacientes sometidos a la colocación de balón intragástrico (BIG) en un hospital de referencia de la Región Norte entre 2019 y 2024. Métodos: Estudio observacional, retrospectivo, descriptivo y analítico, realizado mediante la revisión de historias clínicas electrónicas en el Servicio de Endoscopia de un hospital en Belém, Pará. Se incluyeron pacientes de ambos sexos, con edad ≥18 años, registros completos y un seguimiento mínimo de seis meses. Las variables sociodemográficas, clínicas y antropométricas fueron analizadas con los programas Microsoft® Excel® 2016 y BioEstat 5.4, aplicando las pruebas de Chi-cuadrado, G de bondad de ajuste, t de Student pareada y Kruskal-Wallis, con α = 0,05. Resultados: La muestra incluyó 73 pacientes, predominantemente mujeres (60,3%), con una edad media de 39,8 años. Se observó una pérdida ponderal media de 19,2 kg (11,2%) y una reducción significativa del IMC (p < 0,0001). Las complicaciones fueron poco frecuentes, principalmente náuseas y dolor abdominal. El seguimiento multidisciplinario ocurrió en el 97,3% de los casos, destacándose Nutrición, Psicología y Endocrinología. Conclusión: El BIG demostró ser seguro y eficaz, con baja tasa de complicaciones y resultados ponderales significativos, potenciados por la adhesión al seguimiento multidisciplinario.
Referencias
ABEID M, et al. Efficacy and safety of intragastric balloon placements in 1600 cases: an experience from the Middle East. Obes Surg, 2019; 29(7): 2087-2091.
BARRICHELLO S, et al. Gastric emptying and its correlation with weight loss and body mass index in patients with an intragastric balloon: a prospective study with six years of follow-up. Cureus, 2022; 14(12): e32599.
BAZERBACHI F, et al. Endoscopic bariatric therapy: a guide to the intragastric balloon. Am J Gastroenterol, 2019; 114(9): 1421-1431.
BORGES AC, et al. Intragastric balloons in high-risk obese patients in a Brazilian center: initial experience. Rev Col Bras Cir, 2018; 45(1): e1448.
CANAZAS VMA, et al. Tendência temporal da obesidade em adultos usuários da atenção primária à saúde do Sistema Único de Saúde no período 2008-2023. Revista Observatorio de laEconomíaLatinoamericana, 2024; 22(7): 1-19.
DIAB AF, et al. The effect of age, gender, and baseline BMI on weight loss outcomes in obese patients undergoing intragastric balloon therapy. Obes Surg, 2019; 29(11): 3542-3546.
FRIO GS, et al. The disruption of elective procedures due to COVID-19 in Brazil in 2020. Sci Rep, 2022; 12(1): 10942.
GALVÃO NETO M, et al. Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases. Surg ObesRelat Dis, 2018; 14(2): 151-159.
JENSE MTF, et al. The swallowable intragastric balloon combined with lifestyle coaching: short-term results of a safe and effective weight loss treatment for people living with overweight and obesity. Obes Surg, 2023; 33(6): 1668-1675.
JEREZ J, et al. Intragastric balloon and impact on weight loss: experience in Quito, Ecuador. Arq Bras Cir Dig, 2023; 36: e1731.
KEREN D, RAINIS T. Intragastric balloons for overweight populations — one year post removal. ObesSurg, 2018; 28: 2368-2373.
KHAN MS, et al. A single-center experience of safety and effectiveness of adjustable intragastric balloon in patients with super obesity. Saudi J Gastroenterol, 2025; 31(2): 93-99.
MARRERO TORRES RJ, et al. Fluid-filled intragastric balloons are an effective and safe weight loss option across BMI and age ranges. Surg Endosc, 2022; 36(7): 5160-5166.
MASUKO TM, et al. Cirurgia bariátrica e a pandemia do novo coronavírus: análise comparativa do impacto em procedimentos do SUS e de convênio. BioScience, 2023; 81(1): 17-20.
MIGOWSKI A, COSTA GTL. Análise temporal da prevalência da obesidade e do sobrepeso no Brasil entre 2006 e 2023: evidências a partir dos dados do Vigitel. OnScience, 2024; 2(1): e00104.
NUNES GC, SILVA LB. Nutritional follow-up during intragastric balloon treatment. In: GALVÃO NETO M, SILVA L, USUY JR E, CAMPOS J (eds). Intragastricballoon for weight management. Springer, Cham, 2020; p. 1-10.
PASCHOALOTTO MAC, et al. Regionalização da saúde no Brasil: desigualdades socioeconômicas e na performance em saúde. Gestão & Regionalidade, 2022; 38(113): 1-15.
PEREYRA-TALAMANTES A, et al. Benefits of multidisciplinary team management of obese patients with intragastric balloon placement: an analysis of 159 cases at a single center. Surg ObesRelat Dis, 2020; 16(12): 2068-2073.
PINHO AC, et al. Intragastric balloon as a first step before metabolic bariatric surgery in patients with BMI ≥ 50 kg/m²: are the results after balloon related to global outcomes after surgery? Obes Surg, 2024; 34(9): 3195-3202.
VARGAS EJ, et al. Effectiveness of online aftercare programs following intragastric balloon placement for obesity is similar to traditional follow-up: a large propensity matched US multicenter study. Obes Surg, 2019; 29: 4036-4042.
VIACAVA F, et al. Desigualdades regionais e sociais em saúde segundo inquéritos domiciliares (Brasil, 1998–2013). Ciência & Saúde Coletiva, 2019; 24(7): 2745–2760.
WIGGINS T, et al. Safety and efficacy of 12-month intra-gastric balloon: series of over 1100 patients. Obes Surg, 2024; 34(1): 176-182.
